Investors with a lot of money to spend have taken a bullish stance on Novo Nordisk NVO.
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with NVO, it often means somebody knows something is about to happen.
So how do we know what these investors just did?
Today, Benzinga's options scanner spotted 16 uncommon options trades for Novo Nordisk.
This isn't normal.
The overall sentiment of these big-money traders is split between 43% bullish and 25%, bearish.
Out of all of the special options we uncovered, 6 are puts, for a total amount of $210,131, and 10 are calls, for a total amount of $550,131.
What's The Price Target?
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $55.0 and $120.0 for Novo Nordisk, spanning the last three months.
Analyzing Volume & Open Interest
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Novo Nordisk's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Novo Nordisk's whale activity within a strike price range from $55.0 to $120.0 in the last 30 days.
Novo Nordisk Option Volume And Open Interest Over Last 30 Days
Significant Options Trades Detected:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVO | CALL | SWEEP | NEUTRAL | 09/19/25 | $9.85 | $9.7 | $9.7 | $90.00 | $96.9K | 1.2K | 22 |
| NVO | CALL | TRADE | NEUTRAL | 01/15/27 | $20.05 | $19.2 | $19.6 | $90.00 | $84.2K | 262 | 54 |
| NVO | CALL | TRADE | BEARISH | 01/16/26 | $34.85 | $34.8 | $34.8 | $55.00 | $69.6K | 46 | 20 |
| NVO | CALL | SWEEP | BEARISH | 02/21/25 | $12.45 | $12.15 | $12.2 | $75.00 | $61.0K | 240 | 50 |
| NVO | CALL | TRADE | BULLISH | 04/17/25 | $5.4 | $5.35 | $5.4 | $90.00 | $54.0K | 2.2K | 272 |
About Novo Nordisk
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Where Is Novo Nordisk Standing Right Now?
- With a trading volume of 6,319,073, the price of NVO is up by 0.13%, reaching $88.08.
- Current RSI values indicate that the stock is may be approaching overbought.
- Next earnings report is scheduled for 9 days from now.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Novo Nordisk with Benzinga Pro for real-time alerts.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
